TELA Bio (TELA) Current Assets (2018 - 2026)

TELA Bio's Current Assets history runs 9 years deep, the most recent figure standing at $64.3 million for Q1 2026.

• On a quarterly basis, Current Assets fell 7.8% year-over-year to $64.3 million in Q1 2026; TTM through Mar 2026 was $64.3 million, a 7.8% decrease from a year earlier, with the FY2025 full-year figure at $75.6 million, down 3.19% from the prior year.
• Current Assets eased to $64.3 million in Q1 2026 per TELA's latest filing, from $75.6 million in the prior quarter.
• Across five years, Current Assets topped out at $89.2 million in Q2 2023 and bottomed at $44.1 million in Q3 2024.
• The 5-year median for Current Assets is $62.6 million (2024), against an average of $64.2 million.
• Across the five-year window, Current Assets surged 95.4% in 2023 and sank 46.35% in 2024, its largest moves.
• Year by year, Current Assets stood at $62.4 million in 2022, then climbed by 14.86% to $71.7 million in 2023, then grew by 8.85% to $78.1 million in 2024, then slipped by 3.19% to $75.6 million in 2025, then dropped by 14.92% to $64.3 million in 2026.
• Per Business Quant, the three latest TELA Current Assets figures stand at $64.3 million (Q1 2026), $75.6 million (Q4 2025), and $56.0 million (Q3 2025).